Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

CUSIP: 68236X100

Q4 2023 13F Holders as of 31 Dec 2023

Security identity 2 facts
Shares outstanding
101,268,340
Holder snapshot 8 facts
Share change
+3,193,777
Reported price per share
$2.04
Number of holders
44
Value change
+$6,554,810
Number of buys
24
Number of sells
13

Security key

68236X100

Report period

Q4 2023

Institutions

44

Top holders

10

Ownership snapshot

Top reported holders of TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FMR LLC
13D/G signal
Evidence rows
15
Latest as of
30 Sep 2023
13F Lead comparable stake: 4.7% Showing 1-6 of 15 holder rows.

Rank 1 holder

FMR LLC

13F
Ownership
4.7%
Position
$6.66M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
4.7%
$6,655,856
4,754,183 shares
30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
1.7%
$2,461,248
1,758,034 shares
30 Sep 2023
Triatomic Management LP
13F
Company
13F
0.89%
$1,266,565
904,689 shares
30 Sep 2023
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
13F
0.43%
$612,611
437,579 shares
30 Sep 2023
TIFF ADVISORY SERVICES, LLC
13F
Company
13F
0.42%
$592,767
423,405 shares
30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.3%
$427,815
305,501 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
44
Shares
18,436,129
Rows available
44
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
36
Q4 2023 holders
44
Holder diff
8
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .